Lung Disease Therapeutics Market
According to Intent Market Research, the Lung Disease Therapeutics Market is expected to grow from USD 86.3 Billion in 2024-e at a CAGR of 7.6% to touch USD 134.0 Billion by 2030. The Lung Disease Therapeutics Market is dominated by key players such as, AstraZeneca, GlaxoSmithKline plc, Pfizer Inc., Boehringer Ingelheim, Novartis AG, and Johnson & Johnson.